Skip to content

Home-based Exercise in Chronic Kidney Disease

Effects of Home-based Exercise in Advanced Chronic Kidney Disease and End-stage Renal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03621176
Acronym
HBCKD-BCN
Enrollment
57
Registered
2018-08-08
Start date
2018-08-01
Completion date
2019-02-14
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, End-stage Renal Disease

Keywords

Exercise, Health-related quality of life, Physical function, Hemodialysis, Peritoneal dialysis

Brief summary

A home-based exercise program will be implemented in three different groups of participants: advanced chronic kidney disease, end-stage renal disease in substitutive treatment hemodialysis or peritoneal dialysis. Participants will be evaluated before the program, after 3 months and after 6 months from the starting of the program. During the first 3 months the researcher will phone them weekly to reinforce the exercise habit, and during the last three months, there will be no reinforcement. Assessment will include strength, functional capacity, health-related quality of life and depressive symptoms.

Detailed description

Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all. Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms. The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study. Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).

Interventions

OTHERHome-based exercise

A booklet with detailed information will be provided, and the exercises will be previously reviewed with every patient by the researcher. Participants will be encouraged to perform at least 3 sessions per week and monitor their heart rate. They will be instructed that the exercises should be perceived as 'somewhat hard' from a rate of perceived exertion. Adaptations to increase the intensity of the exercises will be provided so that participants can progress in exercise intensity

Sponsors

Consorci Sanitari de Terrassa. Hospital de Terrassa
CollaboratorUNKNOWN
Cardenal Herrera University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants will undertake the exercise intervention. We will compare effects of the intervention between different cohorts included (advanced chronic kidney disease, end-stage renal disease hemodialysis o peritoneal dialysis)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 3 months in hemodialysis treatment * Clinically stable

Exclusion criteria

* Recent cardiac events (less than 3 months) * Unable to exercise

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline sit to stand 10 test at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksSit to stand to sit test 10, time to perform 10 repetitions

Secondary

MeasureTime frameDescription
Change from baseline STS-60 at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksSit to stand to sit test 60, number of repetitions performed during 60 seconds
Change from baseline OLHR at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksOne leg heel rise test, number of repetitions of heel rise to measure triceps strength
Change from baseline Handgrip strength (dynamometry) at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksHandgrip strength measured through a dynamometer
Change from baseline SPPB at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksShort physical performance battery, a combination of walking speed, STS-5 and balance
Change from baseline OLST at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksOne-leg stand test, time to keep the balance in one leg
Change from baseline TUG at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksTimed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again
Change from baseline Six-minute walking test at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeksDistance covered in 6 minutes
Change from baseline Health-related quality of life measured through the Euro quality of life questionnaire, 5 dimensions, at 12 and 24 weeksBaseline,12 weeks, 24 weeksEuroquol 5D questionnaire, scale 0 (worst health) to 100 (best health). 5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression
Change from baseline Beck depression inventory at 12 and 24 weeksBaseline,12 weeks, 24 weeksQuestionnaire to measure depressive symptoms. Range from 0 (normal) to 63 (worst depression)
Change from baseline Human activity profile at 12 and 24 weeks Human activity profileBaseline,12 weeks, 24 weeksQuestionnaire to measure physical activity. Higher score represents higher activity. Measures of average and maximal activity scores are reported. Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.
Change from baseline Physical Activity Scale for the elderly at 12 and 24 weeksBaseline,12 weeks, 24 weeksQuestionnaire to measure physical activity. Higher scores represent higher activity.
Adherence12 weeks, 24 weeksSessions performed/offered x 100
Change from baseline Albumin at 12 and 24 weeksBaseline,12 weeks, 24 weeksSerum albumin in blood for dialysis patients

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026